Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

159
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
159
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct Phenotype and Secondary Metabolite Profile Mark a Dominant <i>Aspergillus flavus</i> Outbreak Strain.

Journal of fungi (Basel, Switzerland)·2026
Same author

Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4.

Journal of clinical microbiology·2026
Same author

Evaluation of Liofilchem Derma-SR-Screen 4-Well Agar Panels in Screening of Terbinafine and Itraconazole Susceptibility in Clinical <i>Trichophyton</i> Isolates.

Journal of fungi (Basel, Switzerland)·2026
Same author

Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM <i>Candida</i> III Multinational European Observational Cohort Study.

Open forum infectious diseases·2026
Same author

Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life Setting.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Antifungal Resistance Surveillance: Insights From National Mycology Reference Centers and Expert Mycology Laboratories.

Open forum infectious diseases·2025

Related Experiment Video

Updated: May 22, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

27.9K

Refractory versus resistant invasive aspergillosis.

Maiken Cavling Arendrup1,2, Catherine Cordonnier3

  • 1Unit of Mycology, Statens Serum Institut, Building 45, room 123, Artillerivej 5, DK-2300 Copenhagen, Denmark.

The Journal of Antimicrobial Chemotherapy
|March 14, 2025
PubMed
Summary
This summary is machine-generated.

Managing invasive aspergillosis (IA) is complex due to host, fungal, and therapy factors. Early assessment of treatment failure is crucial for effective patient management and improved outcomes in IA cases.

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.4K
Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions
09:42

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Published on: May 16, 2020

4.0K

Related Experiment Videos

Last Updated: May 22, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

27.9K
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
09:52

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

10.4K
Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions
09:42

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Published on: May 16, 2020

4.0K

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Invasive aspergillosis (IA) management is challenging with frequent treatment failures.
  • Patient outcomes depend on host factors, fungal characteristics, and therapeutic interventions.
  • Assessing treatment failure in IA is complex but critical for guiding patient care.

Purpose of the Study:

  • To review definitions and approaches for assessing and managing clinical refractoriness or failure in invasive aspergillosis.
  • To highlight the multifactorial nature of IA treatment outcomes.
  • To discuss the impact of drug resistance and diagnostic timeliness on IA management.

Main Methods:

  • Review of literature on invasive aspergillosis management and treatment failure.
  • Analysis of factors contributing to therapeutic outcomes in IA.
  • Discussion of diagnostic advancements and resistance detection in Aspergillus species.

Main Results:

  • Treatment failure in IA is influenced by underlying disease severity, fungal susceptibility, and therapy specifics.
  • Refractoriness can stem from various factors, including suboptimal drug exposure and true drug resistance.
  • Increasing azole resistance in Aspergillus fumigatus, even in azole-naive patients, poses a significant challenge.

Conclusions:

  • Effective IA management requires a comprehensive assessment of host, pathogen, and treatment factors.
  • Timely diagnostics and susceptibility reporting are essential for adapting IA therapy.
  • Addressing challenges in IA treatment failure is vital for improving patient survival rates.